Use of Artificial Intelligence in Improving Outcomes in Heart Disease
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of member benefits, join or renew today.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
In this video, Antonis Armoundas, PhD, principal investigator at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School and Jennifer Hall, PhD, FAHA, Chief of Data Science at the American Heart Association, discuss the recent scientific statement on the rapid growth of artificial intelligence (AI) in healthcare, the challenges in implementation, and best practices for use. The statement outlines a new framework for implementing artificial intelligence (AI) in cardiovascular disease monitoring and prevention.
Recommended Videos
GLP-1 Receptor Agonists: Recent Findings and Tips
Implementing GLP-1 Treatments
The Importance of Consistent GLP-1 Therapies
Managing Obesity: When to Stop GLP-1s, When to Adjust
Sleep Apnea Definition and Prevalence
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.